{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:54:01Z","timestamp":1790265241151,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jhltonline.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.healun.2024.01.012","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:11:55Z","timestamp":1714749115000},"page":"826-831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Sacubitril-valsartan vs ACE\/ARB in pediatric heart failure: A retrospective cohort study"],"prefix":"10.1016","volume":"43","author":[{"given":"Zachariah E.","family":"Hale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6029-6902","authenticated-orcid":false,"given":"Laura","family":"Prichett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7905-005X","authenticated-orcid":false,"given":"Simran","family":"Jandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Ravekes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2024.01.012_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00246-017-1787-2","article-title":"Systematic literature review on the incidence and prevalence of heart failure in children and adolescents","volume":"39","author":"Shaddy","year":"2018","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.healun.2024.01.012_bib2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa021715","article-title":"The incidence of pediatric cardiomyopathy in two regions of the united states","volume":"348","author":"Lipshultz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2024.01.012_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1542\/pir.2016-0168","article-title":"Congestive heart failure in children","volume":"40","author":"Price","year":"2019","journal-title":"Pedia Rev"},{"key":"10.1016\/j.healun.2024.01.012_bib4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","article-title":"Carvedilol for children and adolescents with heart failure: a randomized controlled trial","volume":"298","author":"Shaddy","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2024.01.012_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.109.927988","article-title":"Enalapril in infants with single ventricle: results of a multicenter randomized trial","volume":"122","author":"Hsu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.01.012_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIRCOUTCOMES.108.787176","article-title":"Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease","volume":"1","author":"Pasquali","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.healun.2024.01.012_bib7","unstructured":"FDA. Sacubitril-valsartan [package insert]. Available at: \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/207620s018lbl.pdf\u3009. Updated 2021. Accessed August 15, 2023."},{"key":"10.1016\/j.healun.2024.01.012_bib8","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/eurheartj\/ehs262","article-title":"Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics","volume":"34","author":"Mangiafico","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2024.01.012_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/1755-5922.12053","article-title":"Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat","volume":"32","author":"Dalzell","year":"2014","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.healun.2024.01.012_bib10","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.0000029801.86489.50","article-title":"Comparison of omapatrilat and enalapril in patients with chronic heart failure","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.01.012_bib11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2024.01.012_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jchf.2019.02.015","article-title":"Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF","volume":"7","author":"Balmforth","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"Suppl 4","key":"10.1016\/j.healun.2024.01.012_bib13","doi-asserted-by":"crossref","first-page":"S450","DOI":"10.1016\/j.healun.2020.01.275","article-title":"Valsartan\/sacubitril in pediatric heart failure","volume":"39","author":"Kemna","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.01.012_bib14","article-title":"Acute effects of sacubitril\/valsartan with initial initiation in pediatric patients in the cardiac intensive care unit","author":"Loomba","year":"2023","journal-title":"Pedia Cardiol"},{"key":"10.1016\/j.healun.2024.01.012_bib15","unstructured":"EMA. Entresto (sacubitril\/valsartan). Summary of product characteristics. Available at: \u3008https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/entresto-epar-product-information_en.pdf\u3009. Updated 2023. Accessed August 15, 2023."},{"key":"10.1016\/j.healun.2024.01.012_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009816","article-title":"Baseline characteristics of pediatric patients with heart failure due to systemic left ventricular systolic dysfunction in the PANORAMA-HF trial","volume":"16","author":"Shaddy","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2024.01.012_bib17","unstructured":"Malin B. Summary of the assessment of TriNetX data privacy principles through an empirical analysis. Available at: \u3008https:\/\/trinetx.com\/wp-content\/uploads\/2021\/12\/TriNetX-Empirical-Summary-by-Brad-Malin-2020.pdf\u3009. Updated 2020. Accessed October 23, 2023."},{"key":"10.1016\/j.healun.2024.01.012_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101667","article-title":"Real-world efficacy of tafamidis in patients with transthyretin amyloidosis and heart failure","volume":"48","author":"Ghoneem","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.healun.2024.01.012_bib19","article-title":"Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks","volume":"53","author":"Wang","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.healun.2024.01.012_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021970","article-title":"Atrial fibrillation in patients with cardiomyopathy: Prevalence and clinical outcomes from real-world data","volume":"10","author":"Buckley","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2024.01.012_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13679","article-title":"Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients","volume":"51","author":"Buckley","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.healun.2024.01.012_bib22","article-title":"Serum creatinine reference limits in pediatric population-a single center electronic health record-based database in Taiwan","volume":"9","author":"Chuang","year":"2021","journal-title":"Front Pedia"},{"key":"10.1016\/j.healun.2024.01.012_bib23","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jacc.2017.07.725","article-title":"Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure","volume":"70","author":"Bonnet","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2024.01.012_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2019-000856","article-title":"Accuracy of medical billing data against the electronic health record in the measurement of colorectal cancer screening rates","volume":"9","author":"Rudrapatna","year":"2020","journal-title":"BMJ Open Qual"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824000329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824000329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T19:10:40Z","timestamp":1736968240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249824000329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1053249824000329"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2024.01.012","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sacubitril-valsartan vs ACE\/ARB in pediatric heart failure: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2024.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}